One goal of CeMeT is to assist physicians by providing therapeutic advice based upon a patient’s analyzed metagenome, enabling personalized and targeted treatment. CeMeT’s second goal is to provide information to the general public about how their lifestyle interacts with their metagenome and which conclusions can be drawn from this information.
CeMeT was founded by three professors of the University Tübingen, Drs Ingo Autenrieth, Daniel Huson and Detlef Weigel (Scientific Advisory Board), in cooperation with CeGaT GmbH. This partnership combines expertise in pre-analytics, sequencing, data analysis, microbiology and medicine. Determination, analysis and assessment of the metagenome with state of the art techniques, will be utilized to solve problems arising in the field of medicine.